Healthcare provider profile · identity verified

Mathews Keecheril Philip, MD

Allopathic & Osteopathic Physicians|Family Medicine · THOMASVILLE, NC · NPI 1245461128

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Mathews Keecheril Philip, MD received $47.98 in general payments during 2025 across 2 reported records.

Dexcom, Inc. accounted for 58.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$47.98

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Dexcom, Inc.	Unresolved — no canonical attribution shown	$28.21	58.8%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$19.77	41.2%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$47.98	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Dexcom G6 Transmitter Normalized: dexcom g6 transmitter	Medical Supply	Dexcom, Inc.	$28.21	1	2025
Source payment records 2025-11-25 · Dexcom, Inc. · $28.21 · Open Payments source
The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit	Device	Exact Sciences Corporation	$19.77	1	2025
Source payment records 2025-12-11 · Exact Sciences Corporation · $19.77 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Pravastatin Sodium	Pravastatin Sodium	520	150
Levothyroxine Sodium	Levothyroxine Sodium	486	121
Gabapentin	Gabapentin	478	120
Atorvastatin Calcium	Atorvastatin Calcium	427	117
Amlodipine Besylate	Amlodipine Besylate	420	113
Lisinopril	Lisinopril	394	116
Metformin Hcl	Metformin Hcl	346	97
Albuterol Sulfate Hfa	Albuterol Sulfate	315	61
Omeprazole	Omeprazole	250	68
Pantoprazole Sodium	Pantoprazole Sodium	219	61
Losartan Potassium	Losartan Potassium	192	58
Montelukast Sodium	Montelukast Sodium	174	41
Tizanidine Hcl	Tizanidine Hcl	170	53
Trazodone Hcl	Trazodone Hcl	166	46
Hydrochlorothiazide	Hydrochlorothiazide	160	43
Alprazolam	Alprazolam	159	26
Sertraline Hcl	Sertraline Hcl	157	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	142	26
Tramadol Hcl	Tramadol Hcl	142	30
Rosuvastatin Calcium	Rosuvastatin Calcium	130	36
Jardiance	Empagliflozin	125	38
Famotidine	Famotidine	121	41
Fluticasone Propionate	Fluticasone Propionate	114	39
Prednisone	Prednisone	108	93
Simvastatin	Simvastatin	107	27
Alendronate Sodium	Alendronate Sodium	104	34
Buspirone Hcl	Buspirone Hcl	101	27
Ozempic	Semaglutide	98	21
Lovastatin	Lovastatin	96	23
Metoprolol Succinate	Metoprolol Succinate	96	25
Doxycycline Hyclate	Doxycycline Hyclate	95	80
Fenofibrate	Fenofibrate	94	35
Clonazepam	Clonazepam	87	16
Duloxetine Hcl	Duloxetine Hcl	87	20
Citalopram Hbr	Citalopram Hydrobromide	85	18
Allopurinol	Allopurinol	82	20
Furosemide	Furosemide	80	29
Glipizide Er	Glipizide	80	19
Breo Ellipta	Fluticasone/Vilanterol	79	15
Pregabalin	Pregabalin	79	13
Ropinirole Hcl	Ropinirole Hcl	77	20
Lorazepam	Lorazepam	76	16
Zolpidem Tartrate	Zolpidem Tartrate	72	14
Fluoxetine Hcl	Fluoxetine Hcl	71	16
Atenolol	Atenolol	70	19
Eliquis	Apixaban	69	14
Escitalopram Oxalate	Escitalopram Oxalate	68	15
Glipizide	Glipizide	62	22
Tamsulosin Hcl	Tamsulosin Hcl	60	17
Meloxicam	Meloxicam	57	21
Warfarin Sodium	Warfarin Sodium	56	12
Januvia	Sitagliptin Phosphate	54	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	16
Baclofen	Baclofen	53	15
Mirtazapine	Mirtazapine	53	16
Metoprolol Tartrate	Metoprolol Tartrate	52	20
Potassium Chloride	Potassium Chloride	52	25
Symbicort	Budesonide/Formoterol Fumarate	51	suppressed
Ezetimibe	Ezetimibe	50	19
Triamcinolone Acetonide	Triamcinolone Acetonide	48	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Ventolin Hfa	Albuterol Sulfate	38	12
Amoxicillin	Amoxicillin	37	34
Clopidogrel	Clopidogrel Bisulfate	37	11
Methocarbamol	Methocarbamol	37	14
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Valacyclovir	Valacyclovir Hcl	35	suppressed
Xarelto	Rivaroxaban	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Metformin Hcl Er	Metformin Hcl	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Celecoxib	Celecoxib	31	suppressed
Glimepiride	Glimepiride	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Spiriva Handihaler	Tiotropium Bromide	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Fluconazole	Fluconazole	24	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Topiramate	Topiramate	22	suppressed
Mupirocin	Mupirocin	21	18
Myrbetriq	Mirabegron	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Estradiol	Estradiol	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	11
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Diazepam	Diazepam	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	17
Linzess	Linaclotide	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Colchicine	Colchicine	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Finasteride	Finasteride	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Methimazole	Methimazole	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$47.98 · 2 records	Dexcom, Inc.	Dexcom G6 Transmitter, The Cologuard Plus Collection Kit	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error